← All trials
NCT01187966
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2007
- Primary completion
- Oct 1, 2008
- Completion date
- Feb 1, 2009
- First posted
- —
- Last posted
- —
- Enrollment
- 669
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Newron PharmaceuticalsLead sponsor
- University of Rome Tor VergataOverall official - principal investigator
- Sri Ramachandra Medical College, ChennaiOverall official - principal investigator
- J.J Hospital, MumbaiOverall official - principal investigator
- Roby General Hospital, KolkataOverall official - principal investigator
- P.D. Hinduja Hospital and Medical Research Centre, MumbaiOverall official - principal investigator
- Poona Hospital, PuneOverall official - principal investigator
- Ruby Hall Clinic, PuneOverall official - principal investigator
- Vijaya Health Centre, ChennaiOverall official - principal investigator
- Kamakshi Memorial Hospital, ChennaiOverall official - principal investigator
- NIMHANS, BangaloreOverall official - principal investigator
- Jaslok Hospital and Research Centre, Mumbai, IndiaOverall official - principal investigator
- T.N.M.C and B.Y.L Nair Hospital, MumbaiOverall official - principal investigator
- Kovai Medical Centre and Hospital, CoimbatoreOverall official - principal investigator
- Neeta Mehta's Clinic, MumbaiOverall official - principal investigator
- Brain and Mind Institute, NagpurOverall official - principal investigator
- Mallikatta Neuro and Research Centre, MangaloreOverall official - principal investigator
- Sree Chitra Tirual Institute for Sciences and Technology, KerelaOverall official - principal investigator
- Baby Memorial Hospital, CalicutOverall official - principal investigator
- Kerala Institute of Medical Sciences, TrivandrumOverall official - principal investigator
- Vidyasagar Institute of Mental Health and Neurosciences, New DelhiOverall official - principal investigator
- Institute of Human Behaviour and Allied Sciences, Dilshad Garden DelhiOverall official - principal investigator
- Sri Aurbindo Seva Kendra, KolkataOverall official - principal investigator
- Fundeni Hospital, BucurestiOverall official - principal investigator
- colentina Hospital, BucurestiOverall official - principal investigator
- Ospedale dell'Angelo, VeneziaOverall official - principal investigator
- Nizam's Institute of Medical Sciences, Hyderabad, IndiaOverall official - principal investigator
- Ospedale di Viareggio, ViareggioOverall official - principal investigator
- Elias UniversityOverall official - principal investigator
- Emergency Hospital Targu-MuresOverall official - principal investigator
- Emergency Hospital TimisoaraOverall official - principal investigator
- Rehabiliation Hospital, LasiOverall official - principal investigator
- J.S.S. Medical College HospitalOverall official - principal investigator
- Owaisi Hospital & Research CentreOverall official - principal investigator
- University of FerraraOverall official - principal investigator
- University of PalermoOverall official - principal investigator
- Apollo Hospitals, Chennai, IndiaOverall official - principal investigator
- Rajiv Gandhi University of Health SciencesOverall official - principal investigator
- University of Medicine and Pharmacy Cluj-Napoca, RomaniaOverall official - principal investigator
- D'Annunzio University of Chieti–PescaraOverall official - principal investigator
- Spectra Clinical ResearchOverall official - principal investigator
- Postgraduate Institute of Medical Education and ResearchOverall official - principal investigator
- All India Institute of Medical SciencesOverall official - principal investigator
- Chhatrapati Sahuji Maharaj Medical UniversityOverall official - principal investigator
- Care Hospital, HyderabadOverall official - principal investigator
- Dayanand Medical CollegeOverall official - principal investigator
- M.S. Ramaiah Medical College, Bangalore, IndiaOverall official - principal investigator
- Sir Ganga Ram HospitalOverall official - principal investigator
- Vita-Salute University of Milano. ItalyOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.